riegel
individually
administrator
estate
riegel
medtronic
argued
december
decided
february
medical
device
amendments
mda
created
scheme
federal
safety
oversight
medical
devices
sweeping
back
state
oversight
schemes
statute
provides
state
shall
establish
continue
effect
respect
device
intended
human
use
requirement
different
addition
requirement
applicable
federal
law
device
relates
safety
effectiveness
device
matter
included
requirement
applicable
device
relevant
federal
law
mda
calls
federal
oversight
medical
devices
varies
type
device
issue
extensive
oversight
reserved
class
iii
devices
undergo
premarket
approval
process
devices
may
enter
market
fda
reviews
design
labeling
manufacturing
specifications
determines
specifications
provide
reasonable
assurance
safety
effectiveness
manufacturers
may
make
changes
devices
affect
safety
effectiveness
unless
first
seek
obtain
permission
fda
charles
riegel
wife
petitioner
donna
riegel
brought
suit
respondent
medtronic
medtronic
catheter
ruptured
charles
riegel
coronary
artery
heart
surgery
catheter
class
iii
device
received
fda
premarket
approval
riegels
alleged
device
designed
labeled
manufactured
manner
violated
new
york
common
law
district
held
mda
riegels
claims
strict
liability
breach
implied
warranty
negligence
design
testing
inspection
distribution
labeling
marketing
sale
catheter
claim
negligent
manufacturing
insofar
claim
premised
theory
medtronic
violated
federal
law
second
circuit
affirmed
held
mda
clause
bars
claims
challenging
safety
effectiveness
medical
device
marketed
form
received
premarket
approval
fda
pp
federal
government
established
requirement
applicable
medtronic
catheter
within
meaning
medtronic
lohr
interpreted
mda
provision
manner
substantially
informed
fda
regulation
cfr
says
state
requirements
fda
established
specific
counterpart
regulations
specific
requirements
applicable
particular
device
federal
law
premarket
approval
imposes
specific
requirements
applicable
particular
device
fda
requires
device
received
premarket
approval
marketed
without
significant
deviations
specifications
device
approval
application
reason
fda
determined
specifications
provide
reasonable
assurance
safety
effectiveness
pp
petitioner
claims
based
upon
new
york
requirement
respect
medtronic
catheter
different
addition
federal
ones
relate
safety
effectiveness
pp
negligence
claims
impose
requirement
ordinary
meaning
term
see
lohr
supra
cipollone
liggett
group
nothing
mda
contradicts
normal
meaning
pp
ii
rejects
petitioner
contention
duties
underlying
tort
claims
general
duties
requirements
maintained
respect
devices
petitioner
suit
depends
upon
new
york
continu
ing
effect
general
tort
duties
respect
medtronic
catheter
title
cfr
mda
extend
tate
local
requirements
general
applicability
whose
purpose
relates
either
products
addition
devices
unfair
trade
practices
requirements
limited
devices
alter
interpretation
pp
declines
address
first
instance
petitioner
argument
lawsuit
raises
parallel
claims
lohr
supra
affirmed
scalia
delivered
opinion
roberts
kennedy
souter
thomas
breyer
alito
joined
stevens
joined
except
parts
stevens
filed
opinion
concurring
part
concurring
judgment
ginsburg
filed
dissenting
opinion
donna
riegel
individually
tor
estate
charles
riegel
petitioner
medtronic
writ
certiorari
appeals
second
circuit
february
justice
scalia
delivered
opinion
consider
whether
clause
enacted
medical
device
amendments
bars
claims
challenging
safety
effectiveness
medical
device
given
premarket
approval
food
drug
administration
fda
federal
food
drug
cosmetic
act
fdca
stat
amended
et
long
required
fda
approval
introduction
new
drugs
market
statutory
enactment
issue
however
introduction
new
medical
devices
left
largely
supervise
saw
fit
see
medtronic
lohr
regulatory
landscape
changed
complex
devices
proliferated
failed
notably
dalkon
shield
intrauterine
device
introduced
linked
serious
infections
several
deaths
mention
large
number
pregnancies
thousands
tort
claims
followed
bacigal
limits
litigation
dalkon
shield
controversy
view
many
dalkon
shield
failure
aftermath
demonstrated
inability
tort
system
manage
risks
associated
dangerous
devices
see
foote
managing
medical
arms
race
several
adopted
regulatory
measures
including
california
enacted
law
requiring
premarket
approval
medical
devices
cal
stats
ch
see
also
leflar
adler
preemption
pentad
federal
preemption
products
liability
claims
medtronic
rev
identifying
state
statutes
governing
medical
devices
congress
stepped
passage
medical
device
amendments
mda
et
swept
back
state
obligations
imposed
regime
detailed
federal
oversight
mda
includes
express
provision
except
provided
subsection
section
state
political
subdivision
state
may
establish
continue
effect
respect
device
intended
human
use
requirement
different
addition
requirement
applicable
chapter
device
relates
safety
effectiveness
device
matter
included
requirement
applicable
device
chapter
exception
contained
subsection
permits
fda
exempt
state
local
requirements
new
regulatory
regime
established
various
levels
oversight
medical
devices
depending
risks
present
class
includes
devices
elastic
bandages
examination
gloves
subject
lowest
level
oversight
general
controls
labeling
requirements
fda
device
advice
device
classes
http
internet
materials
visited
available
clerk
case
file
class
ii
includes
devices
powered
wheelchairs
surgical
drapes
subject
addition
special
controls
performance
standards
postmarket
surveillance
measures
devices
receiving
federal
oversight
class
iii
include
replacement
heart
valves
implanted
cerebella
stimulators
pacemaker
pulse
generators
fda
device
advice
device
classes
supra
general
device
assigned
class
iii
established
less
stringent
classification
provide
reasonable
assurance
safety
effectiveness
device
purported
represented
use
supporting
sustaining
human
life
use
substantial
importance
preventing
impairment
human
health
presents
potential
unreasonable
risk
illness
injury
ii
although
mda
established
rigorous
regime
premarket
approval
new
class
iii
devices
grandfathered
many
already
market
devices
sold
mda
effective
date
may
remain
market
fda
promulgates
notice
comment
regulation
requiring
premarket
approval
related
provision
seeks
limit
competitive
advantage
grandfathered
devices
receive
new
device
need
undergo
premarket
approval
fda
finds
substantially
equivalent
another
device
exempt
premarket
approval
agency
review
devices
substantial
equivalence
known
process
named
section
mda
describing
review
new
class
iii
devices
enter
market
example
fda
authorized
marketing
devices
granted
premarket
approval
devices
hutt
merrill
grossman
food
drug
law
ed
premarket
approval
rigorous
process
lohr
manufacturer
must
submit
typically
multivolume
application
fda
device
advice
premarket
approval
pma
http
includes
among
things
full
reports
studies
investigations
device
safety
effectiveness
published
reasonably
known
applicant
full
statement
device
components
ingredients
properties
principle
principles
operation
full
description
methods
used
facilities
controls
used
manufacture
processing
relevant
packing
installation
device
samples
device
components
required
fda
specimen
proposed
labeling
deciding
whether
approve
application
agency
may
refer
panel
outside
experts
cfr
may
request
additional
data
manufacturer
fda
spends
average
hours
reviewing
application
lohr
supra
grants
premarket
approval
finds
reasonable
assurance
device
safety
effectiveness
agency
must
weig
probable
benefit
health
use
device
probable
risk
injury
illness
use
may
thus
approve
devices
present
great
risks
nonetheless
offer
great
benefits
light
available
alternatives
approved
example
humanitarian
device
exemption
procedures
ventricular
assist
device
children
failing
hearts
even
though
survival
rate
children
using
device
less
percent
fda
center
devices
radiological
health
summary
safety
probable
benefit
online
http
premarket
approval
process
includes
review
device
proposed
labeling
fda
evaluates
safety
effectiveness
conditions
use
set
forth
label
must
determine
proposed
labeling
neither
false
misleading
completing
review
fda
may
grant
deny
premarket
approval
may
also
condition
approval
adherence
performance
standards
cfr
restrictions
upon
sale
distribution
compliance
requirements
agency
also
free
impose
restrictions
regulation
fda
unable
approve
new
device
proposed
form
may
send
approvable
letter
indicating
device
approved
applicant
submitted
specified
information
agreed
certain
conditions
restrictions
cfr
alternatively
agency
may
send
approvable
letter
listing
grounds
justify
denial
practical
measures
applicant
undertake
make
device
approvable
device
received
premarket
approval
mda
forbids
manufacturer
make
without
fda
permission
changes
design
specifications
manufacturing
processes
labeling
attribute
affect
safety
effectiveness
applicant
wishes
make
change
must
submit
fda
must
approve
application
supplemental
premarket
approval
evaluated
largely
criteria
initial
application
cfr
premarket
approval
devices
subject
reporting
requirements
include
obligation
inform
fda
new
clinical
investigations
scientific
studies
concerning
device
applicant
knows
reasonably
know
cfr
report
incidents
device
may
caused
contributed
death
serious
injury
malfunctioned
manner
likely
cause
contribute
death
serious
injury
recurred
fda
power
withdraw
premarket
approval
based
newly
reported
data
existing
information
must
withdraw
approval
determines
device
unsafe
ineffective
conditions
labeling
see
also
recall
authority
except
otherwise
indicated
facts
set
forth
section
appear
opinion
appeals
device
issue
evergreen
balloon
catheter
marketed
medtronic
inc
class
iii
device
received
premarket
approval
fda
changes
label
received
supplemental
approvals
charles
riegel
underwent
coronary
angioplasty
shortly
suffering
myocardial
infarction
app
pet
cert
right
coronary
artery
diffusely
diseased
heavily
calcified
riegel
doctor
inserted
evergreen
balloon
catheter
patient
coronary
artery
attempt
dilate
artery
although
device
labeling
stated
use
contraindicated
patients
diffuse
calcified
stenoses
label
also
warned
catheter
inflated
beyond
rated
burst
pressure
eight
atmospheres
riegel
doctor
inflated
catheter
five
times
pressure
atmospheres
fifth
inflation
catheter
ruptured
complaint
riegel
developed
heart
block
placed
life
support
underwent
emergency
coronary
bypass
surgery
riegel
wife
donna
brought
lawsuit
april
district
northern
district
new
york
complaint
alleged
medtronic
catheter
designed
labeled
manufactured
manner
violated
new
york
common
law
defects
caused
riegel
suffer
severe
permanent
injuries
complaint
raised
number
claims
district
held
mda
riegel
claims
strict
liability
breach
implied
warranty
negligence
design
testing
inspection
distribution
labeling
marketing
sale
catheter
app
pet
cert
complaint
also
held
mda
negligent
manufacturing
claim
insofar
premised
theory
medtronic
violated
federal
law
app
pet
cert
finally
concluded
mda
donna
riegel
claim
loss
consortium
extent
derivative
claims
see
also
appeals
second
circuit
affirmed
dismissals
concluded
medtronic
clearly
subject
federal
requirement
adhering
standards
contained
individual
federally
approved
premarket
approval
application
riegels
claims
successful
impose
state
requirements
differed
added
federal
requirements
granted
ii
since
mda
expressly
state
requirements
different
addition
requirement
applicable
device
federal
law
must
determine
whether
federal
government
established
requirements
applicable
medtronic
catheter
must
determine
whether
riegels
claims
based
upon
new
york
requirements
respect
device
different
addition
federal
ones
relate
safety
effectiveness
turn
first
question
lohr
majority
interpreted
mda
provision
manner
substantially
informed
fda
regulation
set
forth
cfr
see
also
regulation
says
state
requirements
food
drug
administration
established
specific
counterpart
regulations
specific
requirements
applicable
particular
device
cfr
informed
regulation
concluded
federal
manufacturing
labeling
requirements
applicable
across
board
almost
medical
devices
claims
negligence
strict
liability
issue
lohr
federal
requirements
said
requirements
specific
device
question
reflected
entirely
generic
concerns
device
regulation
generally
disclaimed
conclusion
general
federal
requirements
never
general
state
duties
never
held
occurred
case
hand
based
careful
comparison
state
federal
duties
issue
even
though
review
device
specific
lohr
also
rejected
manufacturer
contention
approval
imposed
requirements
regarded
fact
products
entering
market
may
marketed
long
remain
substantial
equivalents
relevant
devices
qualification
exemption
rather
requirement
see
also
concurring
part
dissenting
part
premarket
approval
contrast
imposes
requirements
mda
interpreted
lohr
unlike
general
labeling
duties
premarket
approval
specific
individual
devices
sense
exemption
federal
safety
review
federal
safety
review
thus
attributes
lohr
found
lacking
review
present
equivalence
safety
opinion
premarket
approval
focused
safety
equivalence
devices
enter
market
never
formally
reviewed
mda
safety
efficacy
fda
may
grant
premarket
approval
determines
device
offers
reasonable
assurance
safety
effectiveness
fda
device
allowed
enter
market
substantial
equivalent
take
particular
form
particular
reason
fda
requires
device
received
premarket
approval
made
almost
deviations
specifications
approval
application
reason
fda
determined
approved
form
provides
reasonable
assurance
safety
effectiveness
iii
turn
second
question
whether
riegels
claims
rely
upon
requirement
new
york
law
applicable
catheter
different
addition
federal
requirements
relates
safety
effectiveness
device
matter
included
requirement
applicable
device
safety
effectiveness
subjects
riegels
claims
critical
issue
whether
new
york
tort
duties
constitute
requirements
mda
lohr
five
justices
concluded
causes
action
negligence
strict
liability
impose
requirement
federal
requirements
specific
medical
device
see
opinion
joined
rehnquist
scalia
thomas
jj
opinion
breyer
adhere
view
interpreting
two
statutes
likewise
held
provision
state
requirements
duties
bates
dow
agrosciences
llc
found
actions
provision
federal
insecticide
fungicide
rodenticide
act
said
certain
impose
continue
effect
requirements
labeling
packaging
addition
different
required
subchapter
discussing
emphasis
added
cipollone
liggett
group
held
actions
provision
public
health
cigarette
smoking
act
said
requirement
prohibition
based
smoking
health
shall
imposed
state
law
respect
advertising
promotion
cigarettes
whose
packages
labeled
accordance
federal
law
see
plurality
opinion
scalia
concurring
judgment
part
dissenting
part
congress
entitled
know
meaning
assign
terms
regularly
used
enactments
absent
indication
reference
state
requirements
includes
duties
plurality
opinion
said
cipollone
liability
premised
existence
legal
duty
tort
judgment
therefore
establishes
defendant
violated
obligation
remedy
limited
damages
liability
award
indeed
designed
potent
method
governing
conduct
controlling
policy
present
case
nothing
contradict
normal
meaning
contrary
context
legislation
excluding
duties
scope
make
little
sense
state
tort
law
requires
manufacturer
catheters
safer
hence
less
effective
model
fda
approved
disrupts
federal
scheme
less
state
regulatory
law
effect
indeed
one
think
tort
law
applied
juries
negligence
standard
less
deserving
preservation
state
statute
regulation
adopted
state
agency
least
expected
apply
analysis
similar
applied
experts
fda
many
lives
saved
device
along
greater
effectiveness
brings
greater
risk
harm
jury
hand
sees
cost
dangerous
design
concerned
benefits
patients
reaped
benefits
represented
justice
breyer
explained
lohr
implausible
mda
meant
grant
greater
power
set
state
standards
addition
federal
standards
single
state
jury
state
officials
acting
state
administrative
legislative
lawmaking
processes
perverse
distinction
required
even
suggested
broad
language
congress
chose
turn
somersaults
create
dissent
narrow
scope
term
requirement
grounds
difficult
believe
congress
without
comment
remove
means
judicial
recourse
consumers
injured
devices
post
opinion
ginsburg
internal
quotation
marks
omitted
explained
exactly
clause
medical
devices
terms
operation
law
enacted
congress
need
seconded
committee
report
pain
judicial
nullification
see
connecticut
nat
bank
germain
job
speculate
upon
congressional
motives
however
indication
available
text
statute
suggests
solicitude
injured
devices
dissent
finds
controlling
overcome
congress
estimation
solicitude
suffer
without
new
medical
devices
juries
allowed
apply
tort
law
case
us
fda
supported
position
taken
opinion
regard
meaning
statute
found
unnecessary
rely
upon
agency
view
think
statute
speaks
clearly
point
issue
however
found
statute
ambiguous
accorded
agency
current
position
deference
dissent
correct
see
post
inasmuch
mere
skidmore
deference
seemingly
issue
degree
deference
might
reduced
fact
agency
earlier
position
different
see
skidmore
swift
mead
good
samaritan
hospital
shalala
course
agency
earlier
position
dissent
describes
length
post
finds
preferable
even
compromised
indeed
deprived
claim
deference
fact
longer
agency
position
dissent
also
describes
great
length
experience
fdca
respect
drugs
food
color
additives
post
two
points
render
conclusion
dissent
seeks
draw
experience
clause
permits
tort
suits
unreliable
established
dissent
assumes
tort
lawsuits
drug
additive
approval
fdca
dissent
believes
clause
permits
tort
lawsuits
medical
devices
hypothesis
permitted
drugs
additives
dissent
believes
congress
wanted
two
regimes
alike
congress
applied
clause
entire
fdca
instead
wrote
clause
applies
medical
devices
riegels
contend
duties
underlying
negligence
claims
even
impose
general
duties
requirements
maintained
respect
devices
brief
petitioner
majority
suggested
otherwise
lohr
see
opinion
breyer
opinion
joined
rehnquist
scalia
thomas
jj
good
reason
language
statute
bear
riegels
reading
mda
provides
state
may
establish
continue
effect
respect
device
requirement
relating
safety
effectiveness
different
addition
federal
requirements
emphasis
added
riegels
suit
depends
upon
new
york
continu
ing
effect
general
tort
duties
respect
medtronic
catheter
nothing
statutory
text
suggests
state
requirement
must
apply
relevant
device
medical
devices
products
actions
general
riegels
argument
contrary
rests
text
fda
regulation
mda
clause
extend
certain
duties
including
tate
local
requirements
general
applicability
purpose
requirement
relates
either
products
addition
devices
requirements
general
electrical
codes
uniform
commercial
code
warranty
fitness
unfair
trade
practices
requirements
limited
devices
cfr
even
assuming
regulation
play
role
defining
mda
scope
provide
unambiguous
support
riegels
position
agency
reading
rule
entitled
substantial
deference
see
auer
robbins
fda
view
put
forward
case
regulation
refer
general
tort
duties
care
underlying
claims
case
device
designed
labeled
manufactured
unsafe
ineffective
manner
brief
amicus
curiae
according
fda
regulation
excludes
requirements
relate
incidentally
medical
devices
requirements
general
tort
duties
care
unlike
fire
codes
restrictions
trade
practices
directly
regulate
device
including
design
find
agency
explanation
less
compelling
since
said
general
requirements
imposed
electrical
codes
uniform
commercial
code
law
regulation
specifically
excludes
portions
cfr
however
support
agency
view
application
case
though
still
failing
explain
electrical
codes
uniform
commercial
code
requirements
different
section
mda
sets
forth
general
rule
state
duties
force
effect
law
whether
established
statute
ordinance
regulation
decision
emphasis
added
sentence
far
comprehensible
fda
view
application
riegels
view
aware
duties
established
decision
duties
aware
duties
relate
solely
medical
devices
riegels
reading
also
tension
regulation
statement
adulteration
misbranding
claims
ha
effect
establishing
substantive
requirement
specific
device
specific
labeling
requirement
different
addition
federal
requirement
ii
surely
means
mda
jury
determination
labeling
pacemaker
violated
state
requirement
additional
warnings
riegels
reading
however
allow
claim
tortious
mislabeling
escape
long
claim
also
brought
objects
medical
devices
think
add
nothing
analysis
confusion
neither
accepting
rejecting
proposition
regulation
properly
consulted
determine
statute
meaning
neither
accepting
rejecting
fda
distinction
general
requirements
directly
regulate
regulate
incidentally
regulation
fails
alter
interpretation
text
insofar
outcome
case
concerned
iv
state
requirements
mda
extent
different
addition
requirements
imposed
federal
law
thus
prevent
state
providing
damages
remedy
claims
premised
violation
fda
regulations
state
duties
case
parallel
rather
add
federal
requirements
lohr
see
also
concurring
part
dissenting
part
district
case
recognized
parallel
claims
see
app
pet
cert
interpreted
claims
assert
medtronic
device
violated
state
tort
law
notwithstanding
compliance
relevant
federal
requirements
see
although
riegels
argue
lawsuit
raises
parallel
claims
made
contention
briefs
second
circuit
raise
argument
petition
certiorari
decline
address
argument
first
instance
foregoing
reasons
judgment
appeals
affirmed
donna
riegel
individually
administrator
estate
charles
riegel
petitioner
medtronic
writ
certiorari
appeals
second
circuit
february
justice
stevens
concurring
part
concurring
judgment
significance
provision
medical
device
amendments
mda
fully
appreciated
many
years
enacted
example
statute
whose
text
general
objective
cover
territory
actually
envisioned
authors
cases
frequently
concluded
ultimately
provisions
laws
rather
principal
concerns
legislators
governed
oncale
sundowner
offshore
services
accordingly
agree
justice
ginsburg
description
actual
history
principal
purpose
provision
issue
case
post
dissenting
opinion
persuaded
text
preempt
state
law
requirements
differ
therefore
write
separately
add
words
mda
history
meaning
requirements
nothing
preenactment
history
mda
suggesting
congress
thought
state
tort
remedies
impeded
development
medical
devices
evidence
suggest
congress
decided
cost
injuries
food
drug
medical
devices
outweighed
solicitude
suffer
without
new
medical
devices
juries
allowed
apply
tort
law
innovations
ante
opinion
policy
argument
advanced
congress
justice
ginsburg
persuasively
explains
overriding
purpose
legislation
provide
additional
protection
consumers
withdraw
existing
protections
development
state
premarket
regulatory
regimes
explained
need
provision
conflicting
administrative
rules
see
medtronic
lohr
plurality
opinion
hen
congress
enacted
primarily
concerned
problem
specific
conflicting
state
statutes
regulations
rather
general
duties
enforced
actions
language
provision
reaches
beyond
regulatory
regimes
encompass
types
requirements
rules
administered
judges
like
statutes
regulations
create
define
legal
obligations
unquestionably
qualify
requirements
see
cipollone
liggett
group
damages
actions
sort
raised
petitioner
premised
existence
legal
duty
difficult
say
actions
impose
prohibitions
essence
common
law
enforce
duties
either
affirmative
requirements
negative
prohibitions
plurality
opinion
emphasis
added
although
rules
qualify
requirements
correctly
points
five
justices
lohr
concluded
causes
action
negligence
strict
liability
issue
case
imposed
requirements
federal
requirements
specific
medical
device
moreover
agree
cogent
explanation
riegels
claims
predicated
new
york
duties
constitute
requirements
respect
device
issue
differ
federal
requirements
relating
safety
effectiveness
therefore
join
judgment
opinion
except
parts
donna
riegel
individually
administrator
estate
charles
riegel
petitioner
medtronic
writ
certiorari
appeals
second
circuit
february
justice
ginsburg
dissenting
medical
device
amendments
mda
act
stat
construed
cut
deeply
domain
historically
occupied
state
law
mda
preemption
clause
holds
spares
medical
device
manufacturers
personal
injury
claims
alleging
flaws
design
label
application
design
label
gained
premarket
approval
food
drug
administration
fda
state
damages
remedy
instructs
persists
claims
premised
violation
fda
regulations
ante
dissent
today
constriction
state
authority
congress
view
intend
effect
radical
curtailment
state
suits
seeking
compensation
injuries
caused
defectively
designed
labeled
medical
devices
congress
reason
enacting
evident
federal
government
engage
premarket
regulation
medical
devices
acted
fill
void
adopting
regulatory
systems
medical
devices
section
responded
state
regulation
particularly
california
system
premarket
approval
medical
devices
preempting
state
initiatives
absent
fda
permission
see
purpose
congress
ultimate
touchstone
analysis
cipollone
liggett
group
internal
quotation
marks
omitted
courts
long
presumed
congress
cavalierly
causes
action
medtronic
lohr
preemption
analysis
starts
assumption
historic
police
powers
superseded
unless
clear
manifest
purpose
congress
rice
santa
fe
elevator
assumption
provides
assurance
balance
disturbed
unintentionally
congress
unnecessarily
courts
jones
rath
packing
citation
omitted
presumption
preemption
heightened
federal
law
said
bar
state
action
fields
traditional
state
regulation
new
york
state
conference
blue
cross
blue
shield
plans
travelers
ins
given
traditional
primacy
state
regulation
matters
health
safety
lohr
courts
assume
state
local
regulation
related
matters
normally
coexist
federal
regulations
hillsborough
county
automated
medical
laboratories
federal
laws
containing
preemption
clause
automatically
escape
presumption
preemption
see
bates
dow
agrosciences
llc
lohr
preemption
clause
tells
us
congress
intended
supersede
modify
state
law
extent
absence
legislative
precision
however
courts
may
face
task
determining
substance
scope
congress
displacement
state
law
text
preemption
clause
open
one
plausible
reading
courts
ordinarily
accept
reading
disfavors
bates
ii
mda
preemption
clause
state
political
subdivision
state
may
establish
continue
effect
respect
device
intended
human
use
requirement
different
addition
requirement
applicable
chapter
device
relates
safety
effectiveness
device
matter
included
requirement
applicable
device
chapter
absent
indication
reference
state
includes
duties
ante
regarding
mda
however
indication
bsent
contextual
examination
act
convinces
inclusion
term
requirement
prompt
sweeping
preemption
claims
relief
state
tort
congress
enacted
mda
provide
safety
effectiveness
medical
devices
intended
human
use
stat
preamble
series
medical
device
failures
caused
extensive
injuries
loss
life
propelled
adoption
conspicuous
among
failures
dalkon
shield
intrauterine
device
used
approximately
million
women
see
northern
dist
dalkon
shield
iud
prods
liability
litigation
ante
aggressively
promoted
safe
effective
form
birth
control
dalkon
shield
linked
deaths
miscarriages
middle
early
lawsuits
seeking
compensatory
punitive
damages
totaling
million
filed
given
publicity
attending
dalkon
shield
litigation
congress
awareness
suits
time
mda
consideration
find
informative
absence
sign
legislative
design
preempt
state
tort
recognizes
prevent
state
providing
damages
remedy
claims
premised
violation
fda
regulations
ante
remedy
although
important
help
consumers
injured
devices
receive
fda
approval
nevertheless
prove
unsafe
mda
failure
create
federal
compensatory
remedy
consumers
suggests
congress
intend
broadly
preempt
state
suits
grounded
allegations
independent
fda
requirements
difficult
believe
congress
without
comment
remove
means
judicial
recourse
large
numbers
consumers
injured
defective
medical
devices
silkwood
former
chief
counsel
fda
explained
fda
view
fda
product
approval
state
tort
liability
usually
operate
independently
providing
significant
yet
distinct
layer
consumer
protection
fda
regulation
device
anticipate
protect
safety
risks
individual
consumers
even
thorough
regulation
product
critical
medical
device
may
fail
identify
potential
problems
presented
product
regulation
protect
possible
injuries
might
result
use
device
time
preemption
claims
result
loss
significant
layer
consumer
protection
porter
lohr
decision
fda
perspective
position
food
drug
cf
brief
amicus
curiae
pet
cert
smiths
industries
medical
systems
kernats
pp
dept
health
human
services
public
health
service
advisory
opinion
docket
letter
hile
associate
regulatory
affairs
national
women
health
network
mar
construction
perverse
effect
granting
broad
immunity
entire
industry
judgment
congress
needed
stringent
regulation
lohr
plurality
opinion
exemption
liability
tort
litigation
mda
grant
fda
authority
order
certain
remedial
action
inter
alia
concludes
device
presents
unreasonable
risk
substantial
harm
public
health
notice
defect
sufficient
eliminate
unreasonable
risk
thus
fda
may
order
manufacturer
repair
device
replace
refund
purchase
price
cease
distribution
recall
device
prospect
ameliorative
action
fda
however
lends
support
conclusion
congress
intended
largely
preempt
state
suits
quite
opposite
section
ompliance
order
issued
section
shall
relieve
person
liability
federal
state
law
provision
anticipates
damages
economic
loss
value
remedy
subtracted
congress
enacted
mda
decades
regulating
drugs
food
color
additives
federal
food
drug
cosmetic
act
fdca
stat
amended
et
seq
fdca
contains
preemption
clause
thus
interpretation
bearing
tort
suits
involving
drugs
additives
confinement
medical
devices
hardly
renders
irrelevant
proper
construction
mda
preemption
provision
long
history
federal
state
controls
drugs
additives
interest
public
health
welfare
congress
experience
regulating
drugs
additives
informed
part
provided
model
regulation
medical
devices
therefore
turn
examination
experience
starting
fdca
required
new
drugs
undergo
preclearance
fda
marketed
see
stat
nothing
fdca
text
legislative
history
suggested
fda
preclearance
immunize
drug
manufacturers
tort
time
congress
enacted
mda
state
claims
drug
labeling
design
defects
continued
unabated
despite
nearly
four
decades
fda
congress
inclusion
preemption
clause
mda
motivated
concern
similar
state
tort
actions
mounted
regarding
medical
rather
congress
included
empower
fda
exercise
control
state
premarket
approval
systems
installed
time
preclearance
federal
level
see
supra
infra
congress
enacted
series
premarket
approval
requirements
first
drugs
additives
premarket
control
already
noted
commenced
drugs
congress
required
premarket
approval
food
additives
food
additives
amendment
stat
amended
required
premarket
approval
color
additives
color
additive
amendments
stat
amended
expanded
premarket
approval
process
new
drugs
include
review
effectiveness
drug
amendments
stat
amended
et
seq
required
premarket
approval
new
animal
drugs
animal
drug
amendments
stat
amended
none
acts
contained
preemption
clause
measures
listed
like
mda
enacted
personal
injury
litigation
defective
products
prominent
part
legal
time
enactment
state
regulations
required
premarket
approval
drugs
additives
question
preemption
clause
needed
check
potentially
conflicting
state
regulatory
regimes
see
brief
edward
kennedy
et
al
amici
curiae
different
situation
existed
medical
devices
congress
developed
passed
mda
house
report
observed
absence
effective
federal
regulation
medical
devices
established
programs
comprehensive
state
regulation
committee
aware
california
adopted
sherman
food
drug
cosmetic
law
law
requires
premarket
approval
new
medical
devices
requires
compliance
device
manufacturers
good
manufacturing
practices
authorizes
inspection
establishments
manufacture
devices
implementation
sherman
law
resulted
requirement
intrauterine
devices
subject
premarket
clearance
california
emphasis
added
sum
state
premarket
regulation
medical
devices
design
suppress
tort
suits
accounts
congress
inclusion
preemption
clause
mda
clause
figures
earlier
federal
laws
regulating
drugs
additives
installed
comparable
control
regimes
areas
congress
experience
regulating
drugs
also
casts
doubt
medtronic
policy
arguments
reading
preempt
state
tort
claims
section
must
preempt
state
suits
medtronic
contends
congress
wanted
state
juries
fda
finding
medical
device
safe
effective
used
directed
brief
respondent
similarly
minded
ante
process
approving
new
drugs
least
rigorous
premarket
approval
process
medical
courts
considered
question
overwhelmingly
held
fda
approval
new
drug
application
preempt
state
tort
decades
drug
regulation
thus
indicate
contrary
medtronic
argument
congress
regard
fda
regulation
state
tort
claims
mutually
exclusive
iii
refusing
read
automatic
bar
state
tort
claims
hardly
render
fda
premarket
approval
medtronic
medical
device
application
irrelevant
instant
suit
first
provision
foreclose
negative
implication
possibility
implied
conflict
preemption
geier
american
honda
motor
brackets
internal
quotation
marks
omitted
see
also
freightliner
myrick
accordingly
medical
device
manufacturer
may
dispositive
defense
identify
actual
conflict
plaintiff
theory
case
fda
premarket
approval
device
question
currently
postured
case
presents
occasion
take
issue
medtronic
relies
exclusively
argue
conflict
preemption
second
medical
device
manufacturer
may
entitled
interpose
regulatory
compliance
defense
based
fda
approval
premarket
application
treat
regulatory
compliance
dispositive
regard
one
factor
taken
account
jury
see
sharkey
federalism
action
fda
regulatory
preemption
pharmaceutical
cases
state
versus
federal
courts
law
see
also
restatement
third
torts
proposed
final
draft
apr
manufacturer
present
fda
approval
medical
device
evidence
used
due
care
design
labeling
product
broad
reading
saves
manufacturer
need
urge
defenses
instead
regardless
strength
plaintiff
case
suits
barred
ab
initio
constriction
state
authority
ordered
today
mandated
congress
odds
mda
central
purpose
protect
consumer
safety
reasons
stated
hold
preempt
riegel
suit
therefore
reverse
judgment
appeals
relevant
part
footnotes
unqualified
et
seq
numbers
hereinafter
refer
sections
district
later
granted
summary
judgment
medtronic
claims
riegel
found
medtronic
breached
express
warranty
negligent
manufacturing
comply
federal
standards
app
pet
cert
consequently
granted
summary
judgment
well
donna
riegel
derivative
consortium
claim
ibid
appeals
affirmed
determinations
us
charles
riegel
died
donna
riegel
petitioner
behalf
administrator
husband
estate
simplicity
sake
terminology
opinion
draws
distinction
charles
riegel
estate
charles
riegel
refers
claims
belonging
riegels
riegels
point
authorizes
fda
exempt
state
requirements
circumstances
rarely
met
duties
law
permits
agency
exempt
certain
requirements
suggest
requirements
exist
riegels
also
invoke
provides
compliance
certain
fda
orders
shall
relieve
person
liability
federal
state
law
indicates
claims
held
lohr
possibly
mean
claims
since
deprive
mda
clause
content
provides
guidance
claims
contrary
justice
stevens
contention
post
advance
argument
merely
suggest
one
speculate
upon
congressional
purposes
best
evidence
found
statute
opinions
joined
five
justices
dispose
riegels
assertion
lohr
held
duties
general
qualify
duties
respect
device
majority
opinion
lohr
also
disavowed
conclusion
stated
believe
mda
statutory
regulatory
language
necessarily
precludes
state
requirements
ever
medtronic
lohr
footnotes
verdicts
juries
obey
rules
however
requirements
kind
juries
apply
rules
make
jury
finding
liability
may
induce
defendant
alter
device
label
render
finding
requirement
within
meaning
mda
requirement
rule
law
must
obeyed
event
jury
verdict
merely
motivates
optional
decision
requirement
bates
dow
agrosciences
llc
reason
mda
grant
single
state
jury
power
whatsoever
set
standard
either
conforms
differs
relevant
federal
standard
agree
colorful
inaccurate
quotation
page
opinion
see
cipollone
liggett
group
plurality
opinion
explaining
fact
scope
limited
positive
enactments
mean
section
claims
proceeding
analyze
petitioner
claims
determine
whether
fact
bates
noting
finding
may
rules
well
statutes
regulations
says
nothing
scope
proceeding
determine
whether
particular
rules
issue
case
satisfied
conditions
footnotes
holding
reach
important
issue
outside
bounds
case
preemptive
effect
evidence
medical
device
defect
comes
light
device
receives
premarket
approval
part
lohr
spoke
part
plurality
unless
otherwise
indicated
citations
opinion
refer
portions
lohr
conveying
opinion
next
provision
allows
political
subdivisions
apply
exemption
requirements
medical
devices
set
fda
requirements
stringent
federal
standards
necessitated
compelling
local
conditions
prescription
indicates
solicitude
state
concerns
embodied
legislation
regulation
show
congress
homed
state
suits
meant
deny
injured
parties
recourse
introducing
bill
senate
sponsor
explained
legislation
written
benefit
doubt
always
given
consumer
consumer
pays
health
life
medical
device
malfunctions
cong
rec
remarks
kennedy
see
significant
defects
cardiac
pacemakers
necessitated
voluntary
recalls
pacemakers
involving
units
since
injuries
recorded
resulted
death
example
deaths
injuries
attributed
heart
valves
deaths
injuries
heart
pacemakers
deaths
injuries
intrauterine
devices
cong
rec
remarks
waxman
fda
search
found
deaths
tied
directly
medical
devices
remarks
nelson
see
also
medtronic
lohr
dalkon
shield
ultimately
linked
thousands
serious
injuries
otherwise
healthy
women
vladeck
preemption
regulatory
failure
pepperdine
rev
october
manufacturer
settled
litigated
approximately
dalkon
shield
cases
sobol
bending
law
story
dalkon
shield
bankruptcy
othing
hearings
committee
reports
debates
lohr
plurality
noted
suggest
ed
proponent
legislation
intended
sweeping
traditional
remedies
manufacturers
distributors
defective
devices
congress
intended
result
failure
even
hint
spectacularly
odd
particularly
since
members
houses
acutely
aware
ongoing
product
liability
litigation
see
also
adler
mann
preemption
medical
devices
courts
run
amok
mo
rev
extent
congress
mentioned
common
law
tort
claims
criticize
suggest
needed
barred
federal
regulation
place
rather
note
demonstrated
additional
protections
consumers
fda
recently
announced
new
position
amicus
brief
see
brief
amicus
curiae
amicus
brief
interpreting
statute
entitled
deference
skidmore
swift
see
mead
weight
accorded
agency
position
skidmore
depend
upon
thoroughness
evident
consideration
validity
reasoning
consistency
earlier
later
pronouncements
factors
give
power
persuade
lacking
power
control
see
also
mead
courts
consider
inter
alia
consistency
persuasiveness
agency
position
good
samaritan
hospital
shalala
consistency
agency
position
factor
assessing
weight
position
fda
view
limited
preemptive
effect
better
comports
presumption
preemption
state
health
safety
protections
well
purpose
history
mda
fda
new
position
entitled
little
weight
regards
unenlightening
possibly
mean
claims
provides
guidance
claims
ante
given
presumption
preemption
operative
even
construing
preemption
clause
see
supra
perceived
lack
guidance
cut
medtronic
favor
contrary
bill
need
create
federal
claim
damages
witnesses
testified
right
action
exist
ed
hearings
subcommittee
senate
committee
commerce
statement
hines
see
also
statement
ladds
act
attempt
modify
restate
common
law
respect
personal
defendants
appears
raised
preemption
defense
state
tort
suits
involving
drugs
see
salmon
parke
davis
north
carolina
law
reyes
wyeth
texas
law
hoffman
sterling
drug
pennsylvania
law
singer
sterling
drug
indiana
law
mccue
norwich
pharmacal
new
hampshire
law
basko
sterling
drug
connecticut
law
stromsodt
north
dakota
law
davis
wyeth
montana
law
roginsky
new
york
law
cunningham
charles
pfizer
stevens
parke
davis
cal
bine
sterling
drug
mo
per
curiam
cases
courts
noted
defendants
interposed
preemption
plea
defense
unsuccessful
see
herman
smith
kline
french
supp
ed
see
also
infra
decisions
see
leflar
adler
preemption
pentad
federal
preemption
products
liability
claims
medtronic
rev
surely
furor
aroused
suggestion
medical
devices
receive
exemption
products
liability
litigation
new
drugs
subject
similar
regulatory
scrutiny
agency
remain
standard
tort
law
regime
porter
lohr
decision
fda
perspective
position
food
drug
preemption
fda
regulation
devices
accorded
entirely
different
weight
private
tort
litigation
counterpart
regulation
drugs
biologics
disparity
neither
justified
appropriate
agency
believe
intended
congress
drug
amendments
reiterated
congress
intent
preempt
claims
relying
state
law
nothing
amendments
shall
construed
invalidating
provision
state
law
valid
absence
amendments
unless
direct
positive
conflict
amendments
provision
state
law
stat
congress
featured
california
regulatory
system
discussion
also
identified
california
system
prime
candidate
exemption
preemption
equirements
imposed
california
statute
house
report
noted
serve
example
requirements
secretary
authorize
continued
provided
application
submitted
state
meets
requirements
pursuant
reported
bill
thus
congress
sought
terminate
state
premarket
approval
systems
rather
place
systems
controlling
authority
fda
process
approving
new
drug
begins
preclinical
laboratory
animal
testing
sponsor
new
drug
submits
investigational
new
drug
application
seeking
fda
approval
test
drug
humans
see
cfr
et
seq
clinical
trials
generally
proceed
three
phases
involving
successively
larger
groups
patients
subjects
phase
several
hundred
subjects
phase
ii
several
hundred
several
thousand
subjects
phase
iii
cfr
completing
clinical
trials
sponsor
files
new
drug
application
containing
inter
alia
full
reports
investigations
showing
whether
drug
safe
use
effective
drug
composition
description
drug
manufacturing
processing
packaging
proposed
labeling
drug
see
tobin
astra
pharmaceutical
hill
searle
vioxx
prods
liability
litigation
supp
ed
la
zyprexa
prods
liability
litigation
supp
edny
weiss
fujisawa
pharmaceutical
supp
ed
perry
novartis
pharma
supp
ed
mcnellis
ex
rel
deangelis
pfizer
civ
jbs
wl
nj
jackson
pfizer
supp
neb
par
pharmaceutical
supp
wd
witczak
pfizer
supp
zikis
pfizer
wl
nd
may
cartwright
pfizer
supp
ed
tex
eve
sandoz
pharmaceutical
ip
wl
sd
caraker
sandoz
pharmaceuticals
supp
sd
motus
pfizer
supp
cd
cal
kociemba
searle
supp
see
fed
reg
preamble
labeling
regulations
discussing
fda
recently
adopted
view
federal
drug
labeling
requirements
preempt
conflicting
state
laws
bextra
celebrex
marketing
sales
practices
prod
liability
litigation
crb
wl
nd
colacicco
apotex
supp
ed
needleman
pfizer
civ
wl
nd
dusek
pfizer
civ
wl
sd
cf
fed
reg
preamble
proposed
rule
soon
address
issue
levine
wyeth
wl
cert
granted
question
presented
case
whether
prescription
drug
labeling
judgments
imposed
manufacturers
food
drug
administration
pursuant
fda
comprehensive
safety
efficacy
authority
federal
food
drug
cosmetic
act
et
preempt
state
law
product
liability
claims
premised
theory
different
labeling
judgments
necessary
make
drugs
reasonably
safe
use
pet
cert
wyeth
levine
